Hong Kong Stock Market Sudden Change | Hengrui Medicine (01276.HK) Surges Over 8% to Hit New High, Institutions Say Company's Performance and BD Progress Expected to Become Important Catalysts.

According to the Securities Times app, Hengrui Medicine (01276.HK) rose by more than 8%, reaching a high of 78.8 Hong Kong dollars during trading, setting a new high for the company since its IPO at 44.05 Hong Kong dollars, up more than 78%. As of the time of writing, it has risen by 7.83%, trading at 77.85 Hong Kong dollars, with a turnover of 2.29 billion Hong Kong dollars.